Marker Therapeutics Inc (MRKR)

[Phantom Lord]

This will more than likely just be a brief Q4 update as the call is the day after Q4 results are due and the announcement of the new pancreatic trial. There is a small possibility they announce another trial as well but I can only be sure of the pancreatic trial. Sounds like they have some manufacturing process updates too. I know they were working on cutting down the manufacturing process time by another 50%. If this is the case that would be a 75% reduction in the original processing time which is pretty big considering it will allow them to dose patients sooner. We'll see what they say come next week but I wouldn't expect much more than this.